A recent Cochrane systematic review has examined the effectiveness of intermittent fasting (IF) for adults who are overweight or obese. The review included data from 22 randomized controlled trials with a total of 1,995 participants. Researchers compared different IF regimens to regular dietary advice, such as continuous calorie restriction, and to no intervention.
The findings indicate that IF leads to little or no difference in weight loss when compared with traditional dieting methods. The evidence supporting this conclusion is considered low to very low certainty and may be affected by bias. The authors also note that the impact of IF on quality of life and adverse side effects remains uncertain due to limited available data.
Obesity continues to be a significant public health issue, commonly treated through continuous reduction in daily caloric intake. However, adherence to these diets can be challenging, often resulting in weight regain over time. This difficulty has contributed to the popularity of fasting programs like IF, which alternate periods of eating with periods of little or no food consumption.
Supporters of IF suggest it offers benefits beyond simple calorie reduction, such as improved insulin sensitivity and increased fat metabolism. Despite these claims, current human clinical evidence does not confirm any clear metabolic advantages for IF over standard calorie restriction.
The review analyzed three main comparisons: IF versus regular dietary advice (RDA), IF versus no intervention, and the safety and participant experience associated with IF. When comparing IF to RDA across 21 studies involving 1,430 participants, there was a mean difference in weight loss of -0.33%, indicating similar outcomes between both approaches. For achieving at least 5% body weight reduction—a key clinical benchmark—the risk ratio was 0.98, showing no increase in likelihood with IF compared to conventional approaches.
Comparing IF with no intervention showed greater average weight loss among those following an intermittent fasting regimen; however, the difference was not considered clearly clinically meaningful and long-term sustainability is still uncertain since most studies only followed participants for six to twelve months.
Quality-of-life outcomes were reported infrequently but did not show significant improvement for those practicing intermittent fasting compared with other diets. Reports on adverse events such as headaches or fatigue were inconsistent and inconclusive regarding whether IF poses higher risks than standard dieting.
The authors conclude that while intermittent fasting may serve as an alternative dietary approach for some individuals based on preference or practicality, it does not provide superior results compared with traditional calorie-restriction methods or standard diets. They recommend caution in interpreting these findings due to short trial durations and overall low certainty of evidence. More robust research will be necessary before making firm clinical recommendations about intermittent fasting's role in weight management.
